Clinical Trial

Emerging Indications for Hyperbaric Oxygen Treatment

Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This study will evaluate the effectiveness of hyperbaric oxygen therapy (HBOT) on treating emerging indications (i.e., conditions that have shown to potentially benefit from HBOT) using the Multicenter Registry for Hyperbaric Oxygen Treatment. The study team aims to collect ongoing data on how well HBOT treats these emerging indications, and to add these data to the growing HBO Registry. The research team hypothesizes that HBOT will result in improvements of the condition of the various emerging indications.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-11-18; most recent amendment 2026-07-02.
Trial Details
NCT Number NCT07240649
Lead Sponsor Jay C. Buckey Jr.
Collaborators: Dartmouth College
Conditions Post-COVID-19 Condition, Ulcerative Colitis, Crohn Disease, Calciphylaxis, Frostbite, Acute COVID-19, Pyoderma Gangrenosum, Pterygium +33 more
Enrollment 100 participants
Start Date 2026-08
Primary Completion 2035-12 (estimated)
Study Completion 2035-12 (estimated)
Updated on ClinicalTrials.gov 2026-07-06